These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27525906)

  • 1. Association between the X-ray repair cross-complementing group 1 Arg194Trp polymorphism and thyroid carcinoma susceptibility: A meta-analysis.
    Zhao JZ; Tan XR; Zhao M; Mao XC; Jiang L
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
    Mao D; Zhang Y; Lu H; Fu X
    Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.
    Zhang Y; Wang Y; Wu J; Li LJ
    Tumour Biol; 2013 Aug; 34(4):2321-7. PubMed ID: 23681796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and prostate cancer risk.
    He F; Li G; Man L; Liu N
    Tumour Biol; 2014 May; 35(5):4041-5. PubMed ID: 24492938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.
    Lu JT; Deng AP; Song J; Zhang L; Luo J
    Oncotarget; 2017 Mar; 8(13):21599-21608. PubMed ID: 28423490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.
    Zhang J; Zeng XT; Lei JR; Tang YJ; Yang J
    Tumour Biol; 2014 Jun; 35(6):5629-35. PubMed ID: 24590265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Li C; Xiang X; Zhou Y
    Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
    Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 Arg194Trp polymorphism and thyroid cancer.
    Liu SY; Xue W
    J Endocrinol Invest; 2020 Jun; 43(6):749-753. PubMed ID: 31820401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
    Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
    Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
    Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z; Hu X; Long J; Su L; Wei B
    Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
    PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.
    Feng YZ; Liu YL; He XF; Wei W; Shen XL; Xie DL
    Tumour Biol; 2014 Nov; 35(11):10677-97. PubMed ID: 25064613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis.
    Xu C; Chen P; Liu W; Gu AH; Wang XR
    Asian Pac J Cancer Prev; 2014; 15(17):7419-24. PubMed ID: 25227852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis.
    Li W; Yang F; Gui Y; Bian J
    Oncol Lett; 2014 Oct; 8(4):1725-1730. PubMed ID: 25202399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the XRCC1 polymorphisms and thyroid cancer risk: a meta-analysis from case-control studies.
    Wu FF; He XF; Shen HW; Qin GJ
    PLoS One; 2014; 9(9):e87764. PubMed ID: 25211472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.